Multi-country, Multi-center Cohort Study of Anti-Mullerian Hormone Profile in Asia Pacific Infertile Patients
NCT ID: NCT04203355
Last Updated: 2019-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2020-01-01
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis
NCT03778359
Cooperative Adenomyosis Network
NCT03230994
Receptivity Assessment of Homogeneous Endometrium in Late Follicle Phase
NCT01533350
Serial Measurement of Serum Antimullerian Hormone in Women Undergoing Laparoscopic Cystectomy of Endometrioma
NCT01065168
Observational Study of Patients Suffering From Endometriosis and Adenomyosis
NCT04862000
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To mainly compare the inter-ethnic difference in age-specific AMH profile in unexplained infertility, male factor infertility, PCOS, Endometriosis etc. subgroups.
To detect the influence of past or present smoking on age-specific AMH levels To study the influence of body mass index (BMI) on age specific AMH levels
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Naive patients who plan to enter their first ovarian stimulation cycles
* Women among 20-43 years old
Exclusion Criteria
* Chemotherapy history
* Alcohol abuse
* Currently taking oral contraceptive pills
20 Years
43 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chii-Ruey Tzeng, MD, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Taipei Medical University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Henan Provincial People Hospital
Zhengzhou, Henan, China
Queen Mary Hospital
Hong Kong, , Hong Kong
Women's center by Motherhood Coimbatore
Bangalore, Karnataka, India
Morula IVF center
Jakarta, , Indonesia
Asada Ladies Clinic
Nagoya, Aichi-ken, Japan
Tropicana Medical Centre
Petaling Jaya, Selangor, Malaysia
Victory ART Lab Fertility Center
Makati City, , Philippines
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea
Taipei University Medical Hospital
Taipei, , Taiwan
Chiang Mai University
Chiang Mai, , Thailand
My Duc Hospital
Ho Chi Minh City, , Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Tzeng CR, Huang Z, Asada Y, Zhang C, Ho MT, Li RHW, Kim JH, Govindarajan M, Vuyavanich T, Sini I, Wong PS, Singh S, Lin WY, Ho NT. Factors affecting the distribution of serum anti-mullerian hormone levels among infertile Asian women: a multi-nation, multi-centre, and multi-ethnicity prospective cohort study. Hum Reprod. 2023 Jul 5;38(7):1368-1378. doi: 10.1093/humrep/dead081.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TMU201912130
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.